Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery

Seoul National University

Status: Completed

Conditions: Recovery Time

Treatments: Drug: Neostigmine + Glycopyrrolate

Study type: Observational

Funder types: Other

Identifiers

NCT06745492

Neostigmine & TOFR 0.7

Details and patient eligibility

About

This study is a prospective observational study. A total of 54 patients were included in this study. We observed the time from neostigmine administration to TOF ratio of 1.0.

Enrollment: 59 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing elective thyroid surgery under general anesthesia
• a body mass index of 18.5-25 kg/m2
• Age ≥ 20

Exclusion criteria

• Refused to participate
• history of hypersensitivity to acetylcholinesterase inhibitor
• neuromuscular disease
• hepatic or renal dysfunction